NEUROPATHIC

Preclinical test indicates potential for treating neuropathic pain: Study

According to the study published in the British Journal of Anaesthesia, the first-in-class drug conceptualised by lead author Dr Gareth Tibbs was found to function according to its design at both the molecular level and as an apparently side-effect-free pain reliever in rats.